Overview

Role of L-citrulline in Prevention of Pregnancy Associated Hypertension

Status:
Recruiting
Trial end date:
2024-07-30
Target enrollment:
Participant gender:
Summary
The target population for our study is healthy nulliparous pregnant women (first pregnancy) between the 12-16 week of pregnancy. If a subject is eligible, written consent will be obtained by person to person contact. Eligible participants will be randomized to receive either daily L-citrulline supplementation or placebo.
Phase:
Phase 1
Details
Lead Sponsor:
The University of Texas Medical Branch, Galveston